ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,578.28
-0.22%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. PTC Therapeutics Inc (PTCT)

  7. PTC Therapeutics Inc (PTCT) Noticias

PTCT PTC Therapeutics Inc

34.69
-1.12 (-3.13%)
31 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
PTC Therapeutics Inc PTCT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-1.12 -3.13% 34.69 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
35.99 35.81 36.82 36.36 35.81
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/5/202407:00PRNUSPTC Therapeutics to Participate at Upcoming Investor..
28/5/202407:30PRNUSPTC Therapeutics Announces Validation of Sepiapterin..
24/5/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202409:12EDGAR2Form 144 - Report of proposed sale of securities
20/5/202411:20PRNUSPTC Therapeutics Announces European Commission Returns..
20/5/202406:20EDGAR2Form 8-K - Current report
20/5/202406:00PRNUSPTC Therapeutics Announces European Commission Returns..
14/5/202406:30PRNUSPTC Therapeutics Announces FDA Acceptance and Priority..
10/5/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202414:30EDGAR2Form 144 - Report of proposed sale of securities
02/5/202407:00PRNUSPTC Therapeutics to Participate at Upcoming Investor..
25/4/202415:05PRNUSPTC Therapeutics Provides Corporate Update and Reports First..
23/4/202415:30PRNUSPTC Therapeutics Reports Inducement Grants Under Nasdaq..
11/4/202407:00PRNUSPTC Therapeutics to Host Conference Call to Discuss First..
28/3/202407:30PRNUSPTC Announces Submission of Sepiapterin MAA for Treatment of..
19/3/202406:30PRNUSPTC Therapeutics Provides Key Regulatory Updates
29/2/202415:05PRNUSPTC Therapeutics Provides Corporate Update and Reports..
27/2/202416:20PRNUSPTC Therapeutics to Participate at Upcoming Investor..
22/2/202415:30PRNUSPTC Therapeutics Reports Inducement Grants Under Nasdaq..
16/2/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202407:00PRNUSPTC Therapeutics to Host Conference Call to Discuss Fourth..
14/2/202414:50EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202406:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202415:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202414:30EDGAR2Form 144 - Report of proposed sale of securities
30/1/202414:25EDGAR2Form 144 - Report of proposed sale of securities
30/1/202414:18EDGAR2Form 144 - Report of proposed sale of securities
30/1/202414:18EDGAR2Form 144 - Report of proposed sale of securities
30/1/202414:17EDGAR2Form 144 - Report of proposed sale of securities
25/1/202415:06EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
PTCT
PTC Therapeutics
TSXV
CXD.P
Chainode Opportunities
BIT
BBY
Best Buy
BIT
S27006
Societe Generale Effekten
BOV
RCFA11
Grupo Rcfa Fundo DE Inve...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados